Lyra Therapeutics, Inc. (LYRA)
NASDAQ·Healthcare·Biotechnology
$0.20
—
Mkt Cap $354.98K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
Implied Upside
+150.0%
Consensus $0.50 vs current $0.20
NASDAQ·Healthcare·Biotechnology
$0.20
—
Mkt Cap $354.98K
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
+150.0%
Consensus $0.50 vs current $0.20